GENETIC PREDISPOSITION TO PHENYTOIN-INDUCED BIRTH DEFECTS
Authors:
- SusanM. StricklerSSSusanM. Strickler
- MargaretA. MillerMMMargaretA. Miller
- Eva AndermannEAEva Andermann
- LindaV. DanskyLDLindaV. Dansky
- Marie-Helene SeniMSMarie-Helene Seni
- StephenP. SpielbergSSStephenP. Spielberg
- 1 October 1985
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 326 (8458) , 746-749
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Variable patterns of malformation in the mouse fetal hydantoin syndromeAmerican Journal of Medical Genetics, 1984
- Teratogenicity of anticonvulsant drugs. I: Review of the literatureAmerican Journal of Medical Genetics, 1984
- H-2 influences phenytoin binding and inhibition of prostaglandin synthesisImmunogenetics, 1984
- Pharmacogenetics and the FetusNew England Journal of Medicine, 1982
- Discordant Expression of Fetal Hydantoin Syndrome in Heteropaternal Dizygotic TwinsNew England Journal of Medicine, 1982
- The Murine Ah locus: In utero toxicity and teratogenesis associated with genetic differences in benzo[a]pyrene metabolismTeratology, 1979
- TheAhLocus: Genetic Regulation of the Metabolism of Carcinogens, Drugs, and Other Environmental Chemicals by Cytochrome P-450-Mediated MonooxygenaseCRC Critical Reviews in Biochemistry, 1979
- Risks to the offspring of women treated with hydantoin anticonvulsants, with emphasis on the fetal hydantoin syndromeThe Journal of Pediatrics, 1976
- The fetal hydantoin syndromeThe Journal of Pediatrics, 1975
- Arene Oxides: A New Aspect of Drug MetabolismScience, 1974